NCT06908642 - Evaluation the Safety of hemay005 Tablets | Biotech Hunter

Enrollment

468

Participants

Timeline

Start Date

December 25, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

April 30, 2025

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Hemay005 tablet

Hemay005 is a small molecule PDE4 inhibitor.

DRUG

Placebo

Placebos are the same as drugs, but contain no Hemay005.

Trial Locations (1)

RECRUITING

The Second Affiliated Hospital of Wannan Medical College, Wuhu